These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21434280)

  • 21. ABCG2: the molecular mechanisms of urate secretion and gout.
    Woodward OM
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F485-8. PubMed ID: 26136557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of conversion of isotopic glycine to uric acid in the normal and gouty human and how this is affected by vitamin E and folic acid.
    BISHOP C; RAND R; TALBOTT JH
    Metabolism; 1955 Mar; 4(2):174-82. PubMed ID: 14355635
    [No Abstract]   [Full Text] [Related]  

  • 23. Purine biosynthesis de novo by lymphocytes in gout.
    Kamoun P; Chanard J; Brami M; Funck-Brentano JL
    Clin Sci Mol Med; 1978 Jun; 54(6):595-601. PubMed ID: 657727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of serum uric acid in cases of hyperuricaemia and gout.
    Pokharel K; Yadav BK; Jha B; Parajuli K; Pokharel RK
    JNMA J Nepal Med Assoc; 2011; 51(181):15-20. PubMed ID: 22335090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute gout attack with normal serum uric acid levels.
    Bădulescu M; Macovei L; Rezuş E
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):942-5. PubMed ID: 25581951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of glycine-15N incorporation into urinary uric acid by adenine-8-13C in normal and gouty subjects.
    Seegmiller JE; Klinenberg JR; Miller J; Watts RW
    J Clin Invest; 1968 May; 47(5):1193-203. PubMed ID: 5645862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purine metabolism in women with primary gout.
    Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil AA
    Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.
    Lin KC; Lin HY; Chou P
    J Rheumatol; 2000 Jun; 27(6):1501-5. PubMed ID: 10852278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid level, gout and bone mineral density: A Mendelian randomization study.
    Lee YH; Song GG
    Eur J Clin Invest; 2019 Sep; 49(9):e13156. PubMed ID: 31294819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout.
    Moriwaki Y; Yamamoto T; Takahashi S; Yamakita J; Tsutsumi Z; Hada T
    J Rheumatol; 2001 Jun; 28(6):1306-10. PubMed ID: 11409124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output.
    Perez-Ruiz F; Calabozo M; Erauskin GG; Ruibal A; Herrero-Beites AM
    Arthritis Rheum; 2002 Dec; 47(6):610-3. PubMed ID: 12522834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal excretion is a cause of decreased serum uric acid during acute gout.
    Zhao T; Lv X; Cao L; Guo M; Zheng S; Xue Y; Zou H; Wan W; Zhu X
    Int J Rheum Dis; 2018 Sep; 21(9):1723-1727. PubMed ID: 30345643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.
    Solomon DH; Glynn RJ; MacFadyen JG; Libby P; Thuren T; Everett BM; Ridker PM
    Ann Intern Med; 2018 Oct; 169(8):535-542. PubMed ID: 30242335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of risk factors influencing the detection rate of urate crystal by dual energy computed tomography].
    Xie YF; Wang Y; Deng XR; Geng Y; Ji LL; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):261-265. PubMed ID: 33879895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical characteristics and renal uric acid excretion in early-onset gout patients].
    Li QH; Liang JJ; Chen LX; Mo YQ; Wei XN; Zheng DH; Dai L
    Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):185-190. PubMed ID: 29518862
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.
    Waldman B; Ansquer JC; Sullivan DR; Jenkins AJ; McGill N; Buizen L; Davis TME; Best JD; Li L; Feher MD; Foucher C; Kesaniemi YA; Flack J; d'Emden MC; Scott RS; Hedley J; Gebski V; Keech AC;
    Lancet Diabetes Endocrinol; 2018 Apr; 6(4):310-318. PubMed ID: 29496472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
    Dehghan A; Köttgen A; Yang Q; Hwang SJ; Kao WL; Rivadeneira F; Boerwinkle E; Levy D; Hofman A; Astor BC; Benjamin EJ; van Duijn CM; Witteman JC; Coresh J; Fox CS
    Lancet; 2008 Dec; 372(9654):1953-61. PubMed ID: 18834626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout.
    Baumgartner S; Yeh LT; Shen Z; Kerr B; Manhard K; Quart B
    J Clin Pharmacol; 2018 Sep; 58(9):1164-1170. PubMed ID: 29733441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
    Miner JN; Tan PK; Hyndman D; Liu S; Iverson C; Nanavati P; Hagerty DT; Manhard K; Shen Z; Girardet JL; Yeh LT; Terkeltaub R; Quart B
    Arthritis Res Ther; 2016 Oct; 18(1):214. PubMed ID: 27716403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with gout differ from healthy subjects in renal response to changes in serum uric acid.
    Liu S; Perez-Ruiz F; Miner JN
    Joint Bone Spine; 2017 Mar; 84(2):183-188. PubMed ID: 27324603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.